Cart
sales@molnova.com
AS1810722
CAS No. 909561-15-5
AS1810722( —— )
Catalog No. M24948 CAS No. 909561-15-5
AS1810722 is an orally active and potent STAT6 inhibitor(IC50 :1.9 nM). AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 222 | In Stock |
|
| 10MG | 357 | In Stock |
|
| 25MG | 597 | In Stock |
|
| 50MG | 851 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAS1810722
-
NoteResearch use only, not for human use.
-
Brief DescriptionAS1810722 is an orally active and potent STAT6 inhibitor(IC50 :1.9 nM). AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
-
DescriptionAS1810722 is an orally active and potent STAT6 inhibitor(IC50 :1.9 nM). AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
-
In Vitro——
-
In VivoAnimal Model:Female Balb/c mice asthmatic model by intraperitoneal injection of ovalbumin (OVA)-containing aluminum hydroxide gel Dosage:0.03-0.3 mg/kg Administration:Orally; 30 min before, and 24 and 48 h after OVA exposure Result:Suppressed eosinophil infiltration in the lung in a dose-dependent manner.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP3A4|STAT6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number909561-15-5
-
Formula Weight477.52
-
Molecular FormulaC25H25F2N7O
-
Purity>98% (HPLC)
-
SolubilityDMSO : 62.5 mg/mL (130.89 mM; Need ultrasonic)
-
SMILESO=C(N)CN1CCN(C2=CC=C(NC3=NC=C4C(N(CC5=CC(F)=CC(F)=C5)C=C4)=N3)C=C2)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nagashima S , Hondo T , Nagata H , et al. Novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potent and orally active STAT6 inhibitors[J]. Bioorg Med Chem, 2009, 17(19):6926-6936.
molnova catalog
related products
-
Dehydroabiethylamine
Dehydroabiethylamine is an inducer of hepatic CYP2B activity.
-
Ginsenoside Rg2
Ginsenoside Rg2 is one of the major active components of ginseng, act as an NF-κB inhibitor.
-
Ellagic Acid Dihydra...
Ellagic Acid Dihydrate inhibit the CYP1A1-dependent activation of benzo[a]pyrene.
